Ilan Kirsch is an expert in the field of Pediatrics. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Ilan Kirsch is a published doctor. He published 34 publications, including: 'Topical resiquimod can induce disease regression, eradicate malignant T cells and enhance T cell effector functions in cutaneous T cell lymphoma.'
![]() |
Dr. Kenneth M. Jaffe, MD |
![]() |
Dr. Abraham B. Bergman, MD
![]() |
![]() |
Dr. Ann N. Champoux, MD
![]() |
![]() |
Dr. Kelly N. Evans, MD |
![]() |
Dr. Eva M. Moore, MD
![]() |
![]() |
Dr. Sarah F. Munson, MD
![]() |
![]() |
Dr. Molly Capron, MD
![]() |
![]() |
Dr. Darren S. Migita, MD
![]() |
![]() |
Dr. Sara P. Chrisman, MD
![]() |
![]() |
Dr. Rita M. Mangione-Smith, MD |
![]() |
Dr. Florence Wu, MD |
![]() |
Dr. Michael G. Leu, MD
![]() |
![]() |
Dr. Andrew W. Hahn, MD |
![]() |
Dr. Erin R. Lane, MD |
![]() |
Dr. Lisa M. Cosgrove, DO
![]() |
![]() |
Dr. Jerry J. Zimmerman, MD
![]() |
![]() |
Dr. Howard E. Jeffries, MD
![]() |